Seattle Biotech Leaders Sound Off On How To Create Anchor Companies
When it comes to the Puget Sound region's biotech industry, is it more important to have big anchor companies or an ever-churning ecosystem of small innovators?
That was one of the questions posed to a panel of three biotech executives last week at an industry forum hosted by news website Xconomy at Fred Hutch.
Leaders from Seattle company Blaze Bioscience and Bothell companies Seattle Genetics (Nasdaq: SGEN) and Alder Biopharmaceuticals (Nasdaq: ALDR) debated whether the loss of some major Seattle biotechs to acquisition is detrimental to the future of the industry here or if retention of independent major companies is the key.
Hey, check out all the research scientist jobs. Post your resume today!
That was one of the questions posed to a panel of three biotech executives last week at an industry forum hosted by news website Xconomy at Fred Hutch.
Leaders from Seattle company Blaze Bioscience and Bothell companies Seattle Genetics (Nasdaq: SGEN) and Alder Biopharmaceuticals (Nasdaq: ALDR) debated whether the loss of some major Seattle biotechs to acquisition is detrimental to the future of the industry here or if retention of independent major companies is the key.
Hey, check out all the research scientist jobs. Post your resume today!